Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSupreme Plc Regulatory News (SUP)

Share Price Information for Supreme Plc (SUP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 137.50
Bid: 137.00
Ask: 138.00
Change: 0.50 (0.36%)
Spread: 1.00 (0.73%)
Open: 138.00
High: 138.00
Low: 137.50
Prev. Close: 137.50
SUP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Year End Trading Update

17 Apr 2023 07:00

RNS Number : 3462W
Supreme PLC
17 April 2023
 

17 April 2023

 

Supreme plc

 

("Supreme," the "Company" or the "Group")

(AIM: SUP)

 

Year End Trading Update

 

Trading for FY23 ahead of consensus expectations2, driven by organic and acquisitive growth

The Company now anticipates trading in FY24 will be slightly ahead of current consensus expectations3.

 

The Board of Supreme, a leading manufacturer, supplier, and brand owner of fast-moving consumer products, is delighted to announce a trading update for the twelve months ended 31 March 2023 ("FY23"). Results for the period will be announced on Wednesday 5 July 2023.

 

Supreme has performed strongly throughout the second half of FY23, delivering organic growth across its core business, supplemented by the earnings from the two vaping acquisitions completed in the first half of the year.

 

The Company expects to report FY23 revenue of at least £150 million (2022: £130.8 million) and Adjusted EBITDA1 of at least £19.3 million (2022: £21.1 million), comfortably ahead of current market expectations2.

 

The Group's Vaping category has delivered another excellent performance, nearly doubling revenues from £43.5 million in FY22 to around £75.0 million in FY23. This record performance, underpinned by the Group's core 88Vape brand, has been buoyed by a number of earnings accretive acquisitions in the period, alongside strong new customer momentum, increased market share on e-liquids and favourable market conditions.

 

The remainder of the Group remains profitable and resilient with the Lighting category showing ongoing signs of recovery.

 

The Company expects bank borrowings net of cash to be neutral as at 31 March 2023, a reduction of £12.9 million since the half year, a reminder of the highly cash-generative nature of the Supreme platform.

 

Last week, Supreme was encouraged to hear of the Government's continued support for Vaping as the "the most effective" smoking cessation tool and the launch of its national "swap to stop campaign" where the government plans to provide vape starter kits to support one million adults to quit smoking over the next two years. Supreme's long-standing and overarching company strategy is to support a tobacco-free Great Britain by offering both credible and safer alternatives to nicotine consumption.

Outlook

 

Looking at FY24, the Group expects to maintain its strong growth trajectory, delivering another strong year of profitable growth. The Group now expects trading for the year ended 31 March 2024 to be slightly ahead of current market expectations3.

 

The Board remains confident that the Group will continue to deliver both organic and acquisition led growth this financial year and beyond.

 

1Adjusted EBITDA means operating profit before depreciation, amortisation, share-based payments charge, fair value movements on non-hedge accounted derivatives and exceptional items (including IPO-related costs).

 

2Company compiled analyst consensus for the year ending 31 March 2023 prior to release of this announcement were revenues of £138 million and Adjusted EBITDA of £18.5 million.

3Company compiled analyst consensus for the year ending 31 March 2024 prior to release of this announcement were revenues of £150.5 million and Adjusted EBITDA of £22.2million.

 

Enquiries:

 

Supreme plc

Sandy Chadha, Chief Executive Officer

Suzanne Smith, Chief Finance Officer

 

via Vigo Consulting

Grant Thornton UK LLP (Nominated Adviser)

Samantha Harrison / Harrison Clarke / Samuel Littler

 

+44 (0)20 7383 5100

Berenberg (Broker)

Mark Whitmore / Marie Moy / Mara Grasso

 

+44 (0)20 3207 7800

Vigo Consulting (Financial Public Relations)

Jeremy Garcia / Kendall Hill

supreme@vigoconsulting.com

+44 (0)20 7390 0230

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 which is part of UK law by virtue of the European Union (withdrawal) Act 2018. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

About Supreme

 

Supreme supplies products across five key categories; batteries, lighting, vaping, sports nutrition & wellness, and branded household consumer goods. The Company's capabilities span from product development and manufacturing through to its extensive retail distribution network and direct to consumer capabilities. This vertically integrated platform provides an excellent route to market for well-known brands and products.

 

The Group has over 3,300 active business accounts with retail customers who manage over 10,000 branded retail outlets. Customers include B&M, Home Bargains, Poundland, Tesco, Sainsburys, Morrisons, Amazon, The Range, Costcutter, Asda, Halfords, Iceland and HM Prison & Probation Service.

 

In addition to distributing globally-recognised brands such as Duracell, Energizer and Panasonic, and supplying lighting products exclusively under the Energizer, Eveready, Black & Decker and JCB licences across 45 countries, Supreme has also developed brands in-house, most notably 88Vape and has a growing footprint in Sports Nutrition and Wellness via its principal brands Sci-MX and Battle Bites.

 

www.investors.supreme.co.uk

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFFFVLSTIRLIV
12
Date   Source Headline
24th Apr 20247:00 amRNSYear End Trading Update
28th Mar 20247:00 amRNSTotal Voting Rights
22nd Mar 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
18th Mar 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
11th Mar 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
4th Mar 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
26th Feb 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
19th Feb 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
6th Feb 20247:00 amRNSCommencement of Share Buyback Programme
29th Jan 20242:42 pmRNSMarket and Trading Update and Share Buyback
5th Jan 20247:00 amRNSAcquisition of protein manufacturing assets
2nd Jan 20247:00 amRNSBlock Admission Return
29th Dec 20237:00 amRNSTotal Voting Rights
1st Dec 20238:58 amRNSGrant of Options and Director Dealing
28th Nov 20237:00 amRNSHalf-year Results
31st Oct 20237:00 amRNSTotal Voting Rights
23rd Oct 20237:00 amRNSAppointment of Nomad and Joint Brokers
18th Oct 20237:01 amRNSVaping Category Update
18th Oct 20237:00 amRNSTrading Statement & Notice of Results
4th Oct 202310:50 amRNSDirector Share Purchase
26th Sep 202312:07 pmRNSResult of AGM
26th Sep 20237:00 amRNSAGM Trading Statement
13th Sep 20238:31 amRNSResponse to Media Speculation
23rd Aug 20237:00 amRNSAvailability of Annual Report & Notice of AGM
5th Jul 20237:01 amRNSSignificant Vaping Distribution Appointment
5th Jul 20237:00 amRNSFinal Results
3rd Jul 20237:00 amRNSBlock Admission of Shares
19th Jun 20239:30 amRNSNotice of Results & Investor Presentation
15th May 20233:07 pmRNSDirector Share Purchase
28th Apr 20237:00 amRNSTotal Voting Rights
20th Apr 202311:56 amRNSHolding(s) in Company
17th Apr 20237:00 amRNSYear End Trading Update
31st Mar 20237:00 amRNSTotal Voting Rights
14th Mar 20232:30 pmRNSDisposal of the IP of T-Juice
28th Feb 202312:34 pmRNSTotal Voting Rights
19th Jan 20237:00 amRNSBlock Admission of Shares
13th Jan 20237:00 amRNSHolding(s) in Company
10th Jan 20232:05 pmRNSSecond Price Monitoring Extn
10th Jan 20232:00 pmRNSPrice Monitoring Extension
10th Jan 20237:00 amRNSStrong Q3 Trading
29th Nov 20227:00 amRNSHalf-year Results
24th Oct 20227:00 amRNSTrading Update and Notice of Results
15th Sep 20225:08 pmRNSResult of AGM
15th Sep 20227:00 amRNSAGM Statement
22nd Aug 202211:06 amRNSSecond Price Monitoring Extn
22nd Aug 202211:00 amRNSPrice Monitoring Extension
15th Aug 20227:00 amRNSAvailability of Annual Report & Notice of AGM
9th Aug 20227:00 amRNSAcquisition of Cuts Ice/Flavour Core trade/assets
8th Aug 20227:00 amRNSGrant of performance share awards to a PDMR
25th Jul 20227:00 amRNSDirector Share Purchase
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.